Aspen Pharmacare Holdings Ltd. faces a European Union antitrust probe for ramping up the price of cancer drugs as the EU joins a global crackdown on the soaring cost of life-saving generic medicines.... READ MORE
The global pharmaceutical market could reach $1.2 trillion by 2016, according to industry sources. But drug companies put much of their attention on developing and marketing proven "me-too" drugs — st...
Herbert Smith Freehills (HSF) and Latham & Watkins won lead roles on Baxter International's acquisition of Claris Injectables for $625m, in a bid by Baxter to expand its portfolio of essential generic...